Skip to content

Anteris Technologies Global

US · AVR #3553 by market cap Listed 2024
6.82 -0.23 -3.26%
Live - 5344 symbols - heartbeat 315s ago · 2026-10-08 08:03
Pre-market 6.85 +0.44%
After-hours 6.88 +0.88%
Market cap
664.67M
P/B
2.64
EPS
-2.55
Reader sentiment Are you bullish or bearish on AVR?

Anonymous reader poll. Unscientific, not investment advice.

Recent news

  • Rating change
    Anteris Technologies Raised to Buy From Spec Buy by Bell Potter AVR.AU
    Dow Jones · 2026/3/9
  • Anteris Technologies Global(AVR.US) 10% Shareholder Sells US$5.79 Million in Common Stock
    Market Newswire · 2026/8/12
  • Rating change
    Barclays Maintains Anteris Technologies Global(AVR.US) With Buy Rating, Raises Target Price to $18
    Market Newswire · 2026/5/15
  • Rating change
    Analysts Offer Insights on Healthcare Companies: Nuvalent (NUVL), Cogent Biosciences (COGT) and Anteris Technologies Global Corp. (AVR)
    TipRanks · 2026/6/1
  • Rating change
    Barclays Maintains Anteris Technologies Global(AVR.US) With Buy Rating, Raises Target Price to $22
    Market Newswire · 2026/2/24
  • Rating change
    Wells Fargo Initiates Anteris Technologies Global(AVR.US) With Buy Rating, Announces Target Price $16
    Market Newswire · 2026/3/11
  • Rating change
    Anteris Technologies Global Corp. (AVR) Gets a Buy From Barclays
    TipRanks · 2026/2/24
  • Rating change
    Analysts Offer Insights on Healthcare Companies: Anteris Technologies Global Corp. (AVR) and Siemens Healthineers AG (OtherSEMHF)
    TipRanks · 2026/5/4
  • Rating change
    TD Cowen Maintains Anteris Technologies Global(AVR.US) With Buy Rating, Maintains Target Price $15
    Market Newswire · 2026/6/30
  • Wells Fargo Maintains Anteris Technologies Global(AVR.US) With Buy Rating, Maintains Target Price $16
    Market Newswire · 2026/8/13
  • Rating change
    Cantor Fitzgerald Sticks to Their Buy Rating for Anteris Technologies Global Corp. (AVR)
    TipRanks · 2026/5/14
  • Rating change
    Barclays Reaffirms Their Buy Rating on Anteris Technologies Global Corp. (AVR)
    TipRanks · 2026/5/15
  • Anteris Technologies Global(AVR.US) 10% Shareholder Buys US$6.71 Million in Common Stock
    Market Newswire · 2026/10/6
  • Rating change
    Barclays Maintains Anteris Technologies Global(AVR.US) With Buy Rating, Cuts Target Price to $17
    Market Newswire · 2026/3/12
  • Anteris Technologies Global(AVR.US) 10% Shareholder Buys US$3.03 Million in Common Stock
    Market Newswire · 2026/10/2
  • Barclays Downgrades Anteris Technologies Global(AVR.US) to Hold Rating, Cuts Target Price to $10
    Market Newswire · 2026/10/7
  • Rating change
    Analysts Offer Insights on Healthcare Companies: Anteris Technologies Global Corp. (AVR) and Kymera Therapeutics (KYMR)
    TipRanks · 2026/6/26
  • Rating change
    Cantor Fitzgerald Remains a Buy on Anteris Technologies Global Corp. (AVR)
    TipRanks · 2026/8/14
  • Rating change
    Analysts Conflicted on These Healthcare Names: Anteris Technologies Global Corp. (AVR), Lifecore Biomedical (LFCR) and Biogen (BIIB)
    TipRanks · 2026/6/18
  • Rating change
    Analysts Offer Insights on NA Companies: BETA Technologies, Inc. Class A (BETA) and Anteris Technologies Global Corp. (AVR)
    TipRanks · 2026/8/13

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-10-08 08:03:19 · For reference only, not investment advice and not tailored to your situation.